Medical News

RSS

FDA approves resumed marketing of Tysabri

The Food and Drug Administration (FDA) today approved an application for resumed marketing of Tysabri (natalizumab) subject to a special restricted distribution program.

5 Jun 2006

The science of sex and gender in human health

The National Institutes of Health (NIH) Office of Research on Women's Health (ORWH), in collaboration with the Food and Drug Administration (FDA) Office of Women's Health (OWH), have announces the launch of a new online course, "The Science of Sex and Gender in Human Health."

5 Jun 2006

Minister upholds Hazardous Products Act by announcing Board of Review for baby walkers

Tony Clement, Canadian Minister of Health, today named the three Board of Review members who will inquire into the April 2004 decision to ban the sale, importation, and advertisement of baby walkers.

5 Jun 2006

Robins are the vector for West Nile virus not crows

GenoMed has underscored the discovery by Connecticut scientists that robins are the vector for West Nile virus in their state, not crows.

5 Jun 2006

Hormone's role in insects could give insight for cancer treatment

Starvation typically has dire consequences for an organism's growth. In the tobacco hawkmoth, tissues starved during the last stage of larval development stop growing because they lack the proper nutrients.

5 Jun 2006

Sunitinib therapy shows promise in children with metastatic gastrointenstinal stromal tumor

Children with a rare digestive-tract cancer that is resistant to front-line therapy have benefited from a newer targeted therapy that has been shown effective in adults, according to data from a small pilot study.

5 Jun 2006

Sunitinib malate shows promise against advanced form of lung cancer

Results of a multi-center clinical study of a drug currently approved for treatment of kidney cancer indicate that it may also be effective for people with recurrent and advanced lung cancer.

5 Jun 2006

Survey examines views and experiences of African-American men

The Washington Post, The Henry J. Kaiser Family Foundation, and Harvard University have released a new comprehensive survey looking at how African-American men view their lives in the United States and their outlook for the future.

5 Jun 2006

Milstein gift seeks cure for antibiotic-resistant TB and malaria

A $7.25 million gift to Weill Medical College of Cornell University will establish the Abby and Howard P. Milstein Chemistry Core Facility and the Abby and Howard P. Milstein Program in Chemical Biology.

5 Jun 2006

HIV testing and additional analysis of national survey on HIV/AIDS

The Centers for Disease Control and Prevention (CDC)'s reported plans to recommend routine HIV testing for patients in health care settings will mark a major change in the way HIV testing is conducted in the United States and is intended to increase testing nationwide.

5 Jun 2006

Sunitinib malate drug shows significant benefits over standard treatment for advanced kidney cancer

According to a new study, the drug sunitinib malate (Sutent.) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC).

5 Jun 2006

Helium-based MRI scans may one day allow closer look at smoker lungs

Aided by a powerful imaging technique, scientists have discovered they can detect smoking-related lung damage in healthy smokers who otherwise display none of the telltale signs of tobacco use.

5 Jun 2006

Trials funded by for-profit organizations more likely to report positive findings

Cardiovascular clinical trials published between 2000 and 2005 were significantly more likely to report positive findings if they were funded by for-profit organizations than those funded by not-for-profit organizations

5 Jun 2006

Taxotere combined with standard chemotherapy improves survival in advanced head and neck cancers

The addition of docetaxel (Taxotere) to an initial chemotherapy regimen for inoperable head and neck cancers reduced mortality by nearly 30 percent over three years following treatment compared to the standard two-drug combination.

5 Jun 2006

Cutera settles patent litigation with Palomar

Cutera today announced that it has settled all patent infringement lawsuits with Palomar Medical Technologies, Inc.

5 Jun 2006

School-based obesity interventions may need to be tailored by gender

A study of 17,000 U.S. adolescents finds that black and Hispanic girls are less physically active than white girls, but that this difference is attributable to the schools they attend

5 Jun 2006

Heel prick test can cause unnecessary parental stress

Virtually all babies in the U.S. have their heels pricked soon after birth to get a blood sample for genetic testing.

5 Jun 2006

West Nile virus DNA vaccine shows promise in phase 1 trial

Vical Incorporated has announced that in a Phase 1 clinical trial, a West Nile virus (WNV) vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated

5 Jun 2006

HHS awards BioShield contract heptavalent botulism antitoxin

HHS has awarded a contract to the Cangene Corporation in the amount of $362,641,105 for 200,000 doses of Heptavalent Botulism Antitoxin.

5 Jun 2006

Migrating wild birds play a key role in transporting highly pathogenic avian influenza

Migrating wild birds have played and will likely continue to play a role in transporting highly pathogenic avian influenza (HPAI) virus, or bird flu, over long distances.

5 Jun 2006